Thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels are increased in inflammatory bowel diseases and correlate with acute phase reactants

✍ Scribed by Saibeni, Simone; Vecchi, Maurizio; Bottasso, Bianca; Spina, Luisa; Bajetta, Mariateresa; De Franchis, Roberto

• Book ID: 123019521
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 181 KB
• Volume: 124
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(03)81060-0